Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI)

4.08
Delayed Data
As of Sep 17
 -0.02 / -0.49%
Today’s Change
2.92
Today|||52-Week Range
4.50
+14.93%
Year-to-Date
No recent news for Brainstorm Cell Therapeutics Inc.

Today’s Trading

Previous close4.10
Today’s open4.10
Day’s range4.02 - 4.10
Volume47,289
Average volume (3 months)109,030
Market cap$90.9M
Data as of 3:59pm ET, 09/17/2019

Growth & Valuation

Earnings growth (last year)-168.27%
Earnings growth (this year)-7.14%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book16.68

Competitors

 Today’s
change
Today’s
% change
ORGSOrgenesis Inc-0.16-3.57%
RKDAArcadia Biosciences ...-0.22-3.67%
BASIBioanalytical System...-0.04-1.10%
FSIFlexible Solutions I...+0.01+0.40%
Data as of 8:00pm ET, 09/17/2019

Financials

Next reporting dateOctober 30, 2019
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$13.9M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating &
Medical Officer
Ralph Z. Kern
Corporate headquarters
New York, New Jersey

Forecasts